Milestone Pharmaceuticals Inc. SEC filings MIST
Milestone Pharmaceuticals Inc. has 421 filings in SEC EDGAR's recent list, going back to Jul 30, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 22, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| EFFECT | Filing | May 26, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| UPLOAD | Letter from the SEC | May 18, 2023 | — |
| EFFECT | Filing | Feb 2, 2022 | — |
| CORRESP | Letter to the SEC | Jan 31, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| EFFECT | Filing | Nov 5, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| EFFECT | Filing | Dec 18, 2020 | — |
| CORRESP | Letter to the SEC | Dec 16, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2020 | — |
| EFFECT | Filing | Jul 6, 2020 | — |
| CORRESP | Letter to the SEC | Jul 1, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2020 | — |
| EFFECT | Filing | May 8, 2019 | — |
| CERT | Filing | May 7, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| 8-A12B | Filing | May 6, 2019 | — |
| CORRESP | Letter to the SEC | Apr 19, 2019 | — |
| CORRESP | Letter to the SEC | Apr 12, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2019 | — |
| DRSLTR | Filing | Mar 15, 2019 | — |
| DRS/A | Filing | Mar 15, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2019 | — |
| DRS/A | Filing | Feb 28, 2019 | — |
| DRSLTR | Filing | Feb 27, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| DRS | Filing | Dec 21, 2018 | — |
| D | Filing | Oct 26, 2018 | — |
| D | Filing | Jul 25, 2017 | — |
| D | Filing | Jun 15, 2015 | — |
| D | Filing | Jun 14, 2011 | — |
| REGDEX | Auto-generated paper document | Jul 30, 2007 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Quebec, Canada
- Headquarters
- Montreal, Quebec, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1408443
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.